EQL Pharma ABOSTO:EQL -2.32%42 Days Inventory is 210.29 as of Mar. 2026, which is 0% below its 10-year median of 210.67. GuruFocus rates OSTO:EQL with a GF Score™ of 42/100. The stock has 4 warning signs investors should review. Among 918 Drug Manufacturers companies, EQL Pharma AB ranks worse than 77.45% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). EQL Pharma AB's Average Total Inventories for the
three
months ended in Mar. 2026 was kr198.6 Mil. EQL Pharma AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was kr86.2 Mil.
Hence, EQL Pharma AB's Days Inventory for the
three
months ended in Mar. 2026 was 210.29.
The historical rank and industry rank for EQL Pharma AB's Days Inventory or its related term are showing as below:
OSTO:EQL'
s Days Inventory Range Over the Past 10 Years
Min: 48.84 Med: 210.67 Max: 258.71
Current: 258.71
During the past 13 years, EQL Pharma AB's highest Days Inventory was 258.71. The lowest was 48.84. And the median was 210.67.
OSTO:EQL's Days Inventory is ranked worse than 77.45% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs OSTO:EQL: 258.71
EQL Pharma AB's Days Inventory
declined
from Mar. 2025 (234.81) to Mar. 2026 (210.29).
Inventory Turnover measures how fast the company turns over its inventory within a year.
EQL Pharma AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.43.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
EQL Pharma AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.65.
EQL Pharma AB (OSTO:EQL) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
EQL Pharma AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
EQL Pharma AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
EQL Pharma AB Days Inventory Related Terms
EQL Pharma AB Days Inventory Historical Data
* Premium members only.
The historical data trend for EQL Pharma AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EQL Pharma AB Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where EQL Pharma AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EQL Pharma AB (OSTO:EQL) has a Days Inventory of 210.29 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on EQL Pharma AB and its competitors. This is near median its historical median of 210.67. Over the past decade, EQL Pharma AB's Days Inventory has ranged from 48.84 to 258.71. According to the industry distribution chart, EQL Pharma AB ranks #711 out of 918 companies in the Drug Manufacturers industry, placing it in the top 77.5%.
Is EQL Pharma AB's Days Inventory too high?
EQL Pharma AB's current Days Inventory of 210.29 is near median its 10-year median of 210.67. Over the past 10 years, this metric has ranged from a low of 48.84 to a high of 258.71. The Drug Manufacturers industry median Days Inventory is 164.43. EQL Pharma AB's value of 210.29 is 27.9% above this industry median. Based on the distribution chart, EQL Pharma AB ranks #711 out of 918 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, EQL Pharma AB has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does EQL Pharma AB's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, EQL Pharma AB ranks #711 out of 918 companies for Days Inventory. This places EQL Pharma AB in the lower half of its industry. The industry median Days Inventory is 164.43. EQL Pharma AB's value of 210.29 is 27.9% above this benchmark. Historically, EQL Pharma AB's own Days Inventory has ranged from 48.84 to 258.71 over the past decade. While the company's 10-year median is 210.67 vs. the industry median of 164.43, EQL Pharma AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EQL Pharma AB's current Days Inventory of 210.29 is 27.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on EQL Pharma AB and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EQL Pharma AB's current Days Inventory is 210.29, which is near median its own 10-year median of 210.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EQL Pharma AB stock overvalued right now?
EQL Pharma AB (OSTO:EQL) has a current Days Inventory of 210.29. The current Days Inventory is 210.29, which is near median its 10-year median of 210.67 and 27.9% above the Drug Manufacturers industry median of 164.43. EQL Pharma AB's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For EQL Pharma AB (OSTO:EQL), the current Days Inventory is 210.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EQL Pharma AB is a pharmaceutical company focused on efficiently and thoughtfully developing and marketing generic drugs. The company operates in one segment, which is medicine. Its niche generics are divided into four parts based on four sales and marketing models: Retail, Hospital, Branded, and Tests. EQL Pharma specializes in identifying, developing, and selling generics, i.e., medicines that are medically equivalent to originator medicines. The company operates in Sweden, Denmark, Norway, Finland, the rest of Europe, and outside Europe, generating the majority of its revenue from Sweden.
42GF Score
Get the complete analysis for OSTO:EQL
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:EQL has been successfully added to your 
